MMED
Get informed when a big investor buys or sells
+ Follow| Market cap | $4.26 Billion |
|---|---|
| Enterprise Value | $4.27 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.89 |
| Beta | 0 |
| Outstanding Shares | 280,813,348 |
| P/E Ratio | -12.98 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 1.26 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | 71,000▲ Infinity% |
Holdings and activity of institutional investors.
| Ownership % | 11.56%▲ 11.56% |
|---|---|
| Total Invested | $484.39M |
| Investors Holding | 60▲ 60.00% |
No data
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion s...